JP Patent

JP4176170B2 — アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬

Assigned to Seikagaku Corp · Expires 2008-11-05 · 18y expired

What this patent protects

Patent listed against eliglustat-tartrate.

Drugs covered by this patent

Patent Metadata

Patent number
JP4176170B2
Jurisdiction
JP
Classification
Expires
2008-11-05
Drug substance claim
No
Drug product claim
No
Assignee
Seikagaku Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.